5 Dividend Kings to Buy for 2022

2. Johnson & Johnson (NYSE:JNJ)

Dividend Yield as of January 19: 2.52%

Number of Hedge Fund Holders: 88

Number of Years of Dividend Increases: 59

Johnson & Johnson (NYSE:JNJ) is an American multinational corporation that deals in medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson (NYSE:JNJ) has a prime credit rating of AAA, and it is one of the most valuable companies in the world. 

Johnson & Johnson (NYSE:JNJ) on January 4 declared a $1.06 per share quarterly dividend, in line with previous. The dividend is payable on March 8, to shareholders of record on February 22. As of January 19, Johnson & Johnson (NYSE:JNJ) offers a 2.52% dividend yield, and is one of the top dividend kings to buy for 2022. 

Credit Suisse analyst Matt Miksic on December 29 reiterated an Outperform rating and a $200 price target on the Johnson & Johnson (NYSE:JNJ) shares. His updated intra-quarter analysis of October and November sales shows approximately $588 million of upside to his estimate for Johnson & Johnson (NYSE:JNJ)’s fourth quarter U.S. pharma business. 

Among the hedge funds monitored by Insider Monkey in Q3 2021, Terry Smith’s Fundsmith LLP is the largest Johnson & Johnson (NYSE:JNJ) shareholder, owning 7.20 million shares worth $1.16 billion. Overall, 88 hedge funds were bullish on Johnson & Johnson (NYSE:JNJ) in the third quarter of 2021, with stakes totaling $6.8 billion. 

Distillate Capital mentioned Johnson & Johnson (NYSE:JNJ) in its Q2 2021 investor letter. Here is what the firm has to say:

“The largest additions in the rebalance, Johnson & Johnson was around 50 and 40 basis points incrementally. J&J underperformed in the quarter while its normalized free cash flows held steady and so its position size was topped off to match the stable cash flows.”